These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 3785643)

  • 1. Alzheimer's disease and serotonin: a review.
    Whitford GM
    Neuropsychobiology; 1986; 15(3-4):133-42. PubMed ID: 3785643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aminergic systems in Alzheimer's disease and Parkinson's disease.
    D'Amato RJ; Zweig RM; Whitehouse PJ; Wenk GL; Singer HS; Mayeux R; Price DL; Snyder SH
    Ann Neurol; 1987 Aug; 22(2):229-36. PubMed ID: 3477996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoaminergic neurotransmitter alterations in postmortem brain regions of depressed and aggressive patients with Alzheimer's disease.
    Vermeiren Y; Van Dam D; Aerts T; Engelborghs S; De Deyn PP
    Neurobiol Aging; 2014 Dec; 35(12):2691-2700. PubMed ID: 24997673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotoninergic impairment and aggressive behavior in Alzheimer's disease.
    Zarros AC; Kalopita KS; Tsakiris ST
    Acta Neurobiol Exp (Wars); 2005; 65(3):277-86. PubMed ID: 16130802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alzheimer's disease: biological diagnosis.
    Ebinger G; Herregodts P; Michotte Y; Vanderheyden P; Vauqelin G
    Acta Neurol Belg; 1989; 89(3-4):132-4. PubMed ID: 2516958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serotonin in aging, late-life depression, and Alzheimer's disease: the emerging role of functional imaging.
    Meltzer CC; Smith G; DeKosky ST; Pollock BG; Mathis CA; Moore RY; Kupfer DJ; Reynolds CF
    Neuropsychopharmacology; 1998 Jun; 18(6):407-30. PubMed ID: 9571651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-hydroxytryptamine and depression: a model for the interaction of normal variance with pathology.
    Goodwin FK; Post RM
    Br J Clin Pharmacol; 1983; 15 Suppl 3(Suppl 3):393S-405S. PubMed ID: 6190490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurotoxic properties of a serotonin oxidation product: possible role in Alzheimer's disease.
    Volicer L; Chen JC; Crino PB; Vogt BA; Fishman J; Rubins J; Schenepper PW; Wolfe N
    Prog Clin Biol Res; 1989; 317():453-65. PubMed ID: 2481322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased platelet serotonin concentration in Alzheimer's disease with involuntary emotional expression disorder.
    Prokšelj T; Jerin A; Muck-Seler D; Kogoj A
    Neurosci Lett; 2014 Aug; 578():71-4. PubMed ID: 24970754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disturbance of the 5-hydroxytryptamine metabolism in brains from patients with Alzheimer's dementia.
    Gottfries CG
    J Neural Transm Suppl; 1990; 30():33-43. PubMed ID: 2202785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amine neurochemistry and aggression in crayfish.
    Panksepp JB; Yue Z; Drerup C; Huber R
    Microsc Res Tech; 2003 Feb; 60(3):360-8. PubMed ID: 12539165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A serotoninergic basis for hyperphagic eating changes in Alzheimer's disease.
    Tsang SW; Keene J; Hope T; Spence I; Francis PT; Wong PT; Chen CP; Lai MK
    J Neurol Sci; 2010 Jan; 288(1-2):151-5. PubMed ID: 19818455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serotonin and aggressive behavior in rodents and nonhuman primates: predispositions and plasticity.
    Ferrari PF; Palanza P; Parmigiani S; de Almeida RM; Miczek KA
    Eur J Pharmacol; 2005 Dec; 526(1-3):259-73. PubMed ID: 16289029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serotonin fibre sprouting and increase in serotonin transporter immunoreactivity in the CA1 area of hippocampus in a triple transgenic mouse model of Alzheimer's disease.
    Noristani HN; Olabarria M; Verkhratsky A; Rodríguez JJ
    Eur J Neurosci; 2010 Jul; 32(1):71-9. PubMed ID: 20576032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Change in certain forms of aggressive behavior and the concentration of monoamines in the brain during selection of wild rats for taming].
    Nikulina EM; Borodin PM; Popova NK
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1985; 35(4):703-9. PubMed ID: 2413648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alzheimer's disease: monoamines and spiperone binding reduced in nucleus basalis.
    Sparks DL; Markesbery WR; Slevin JT
    Ann Neurol; 1986 Jun; 19(6):602-4. PubMed ID: 2425718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of oral administration of chlordecone and mirex on brain biogenic amines in mice.
    Fujimori K; Nabeshima T; Ho IK; Mehendale HM
    Neurotoxicology; 1982 Oct; 3(2):143-8. PubMed ID: 6186959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serotoninergic manipulation of the behavioral effects of cocaine in rats.
    Pradhan SN; Battacharyya AK; Pradhan S
    Commun Psychopharmacol; 1978; 2(6):481-6. PubMed ID: 311720
    [No Abstract]   [Full Text] [Related]  

  • 19. Serotonin, suicide, and aggression: clinical studies.
    Golden RN; Gilmore JH; Corrigan MH; Ekstrom RD; Knight BT; Garbutt JC
    J Clin Psychiatry; 1991 Dec; 52 Suppl():61-9. PubMed ID: 1721619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurosteroids and aggressive behaviour in Alzheimer's disease.
    Pickles VR
    Med Hypotheses; 1994 Apr; 42(4):243-4. PubMed ID: 7915396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.